Gourdie RG - Search Results

1

Novel approach to temozolomide resistance in malignant glioma: connexin43-directed therapeutics.

Grek CL, Sheng Z, Naus CC, Sin WC, Gourdie RG, Ghatnekar GG. Grek CL, et al. Among authors: gourdie rg. Curr Opin Pharmacol. 2018 Aug;41:79-88. doi: 10.1016/j.coph.2018.05.002. Epub 2018 May 24. Curr Opin Pharmacol. 2018. PMID: 29803991 Free PMC article. Review.

2

A synthetic connexin 43 mimetic peptide augments corneal wound healing.

Moore K, Bryant ZJ, Ghatnekar G, Singh UP, Gourdie RG, Potts JD. Moore K, et al. Among authors: gourdie rg. Exp Eye Res. 2013 Oct;115:178-88. doi: 10.1016/j.exer.2013.07.001. Epub 2013 Jul 20. Exp Eye Res. 2013. PMID: 23876491 Free PMC article.

3

Impact of the controlled release of a connexin 43 peptide on corneal wound closure in an STZ model of type I diabetes.

Moore K, Ghatnekar G, Gourdie RG, Potts JD. Moore K, et al. Among authors: gourdie rg. PLoS One. 2014 Jan 23;9(1):e86570. doi: 10.1371/journal.pone.0086570. eCollection 2014. PLoS One. 2014. PMID: 24466155 Free PMC article.

4

The effect of a connexin43-based Peptide on the healing of chronic venous leg ulcers: a multicenter, randomized trial.

Ghatnekar GS, Grek CL, Armstrong DG, Desai SC, Gourdie RG. Ghatnekar GS, et al. Among authors: gourdie rg. J Invest Dermatol. 2015 Jan;135(1):289-298. doi: 10.1038/jid.2014.318. Epub 2014 Jul 29. J Invest Dermatol. 2015. PMID: 25072595 Free PMC article. Clinical Trial.

5

Topical administration of a connexin43-based peptide augments healing of chronic neuropathic diabetic foot ulcers: A multicenter, randomized trial.

Grek CL, Prasad GM, Viswanathan V, Armstrong DG, Gourdie RG, Ghatnekar GS. Grek CL, et al. Among authors: gourdie rg. Wound Repair Regen. 2015 Mar-Apr;23(2):203-12. doi: 10.1111/wrr.12275. Epub 2015 Apr 29. Wound Repair Regen. 2015. PMID: 25703647 Free PMC article. Clinical Trial.

6

Connexin 43 Inhibition Sensitizes Chemoresistant Glioblastoma Cells to Temozolomide.

Murphy SF, Varghese RT, Lamouille S, Guo S, Pridham KJ, Kanabur P, Osimani AM, Sharma S, Jourdan J, Rodgers CM, Simonds GR, Gourdie RG, Sheng Z. Murphy SF, et al. Among authors: gourdie rg. Cancer Res. 2016 Jan 1;76(1):139-49. doi: 10.1158/0008-5472.CAN-15-1286. Epub 2015 Nov 5. Cancer Res. 2016. PMID: 26542214 Free PMC article.

7

A Multicenter Randomized Controlled Trial Evaluating a Cx43-Mimetic Peptide in Cutaneous Scarring.

Grek CL, Montgomery J, Sharma M, Ravi A, Rajkumar JS, Moyer KE, Gourdie RG, Ghatnekar GS. Grek CL, et al. Among authors: gourdie rg. J Invest Dermatol. 2017 Mar;137(3):620-630. doi: 10.1016/j.jid.2016.11.006. Epub 2016 Nov 14. J Invest Dermatol. 2017. PMID: 27856288 Free PMC article. Clinical Trial.

8

Patient-derived glioblastoma stem cells respond differentially to targeted therapies.

Kanabur P, Guo S, Simonds GR, Kelly DF, Gourdie RG, Verbridge SS, Sheng Z. Kanabur P, et al. Among authors: gourdie rg. Oncotarget. 2016 Dec 27;7(52):86406-86419. doi: 10.18632/oncotarget.13415. Oncotarget. 2016. PMID: 27863440 Free PMC article.

9

Targeting the tight junction protein, zonula occludens-1, with the connexin43 mimetic peptide, αCT1, reduces VEGF-dependent RPE pathophysiology.

Obert E, Strauss R, Brandon C, Grek C, Ghatnekar G, Gourdie R, Rohrer B. Obert E, et al. J Mol Med (Berl). 2017 May;95(5):535-552. doi: 10.1007/s00109-017-1506-8. Epub 2017 Jan 28. J Mol Med (Berl). 2017. PMID: 28132078 Free PMC article.

10

Connexin 43-Based Therapeutics for Dermal Wound Healing.

Montgomery J, Ghatnekar GS, Grek CL, Moyer KE, Gourdie RG. Montgomery J, et al. Among authors: gourdie rg. Int J Mol Sci. 2018 Jun 15;19(6):1778. doi: 10.3390/ijms19061778. Int J Mol Sci. 2018. PMID: 29914066 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

161 results

Search Page